ロード中...
Sirolimus blocks the accumulation of hyaluronan (HA) by arterial smooth muscle cells and reduces monocyte adhesion to the ECM
Sirolimus (SRL), an inhibitor of human arterial smooth muscle cell (ASMC) proliferation and migration, prevents in-stent restenosis (ISR). Little is known about the effect of SRL on the extracellular matrix (ECM) component, hyaluronan, a key macromolecule in neointimal hyperplasia and inflammation....
保存先:
主要な著者: | , , , , , , |
---|---|
フォーマット: | Artigo |
言語: | Inglês |
出版事項: |
2006
|
主題: | |
オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2504412/ https://ncbi.nlm.nih.gov/pubmed/17174314 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.atherosclerosis.2006.11.023 |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|